Real-World Experience of Bimekizumab in a Cohort of 109 Patients Over 48 Weeks and Identification of Predictive Factors for an Early Super Response and Risk of Adverse Events

Real-World Experience of Bimekizumab in a Cohort of 109 Patients Over 48 Weeks and Identification of Predictive Factors for an Early Super Response and Risk of Adverse Events

Zeno Fratton,1 Stefano Bighetti,2 Luca Bettolini,2 Vincenzo Maione,2 Mariachiara Arisi,2 Cinzia Buligan,1 Giuseppe Stinco,1 Enzo Errichetti1 1Department of Medicine, Institute of Dermatology, University of Udine, Udine, Friuli Venezia-Giulia, Italy; 2Dermatology Department, University of Brescia, AS...

Full description

Saved in:
Bibliographic Details
Main Authors: Fratton Z, Bighetti S, Bettolini L, Maione V, Arisi M, Buligan C, Stinco G, Errichetti E
Format: Article
Language:English
Published: Dove Medical Press 2025-04-01
Series:Psoriasis: Targets and Therapy
Subjects:
bimekizumab
safety
efficacy
super responder
asthma
nails
Online Access:https://www.dovepress.com/real-world-experience-of-bimekizumab-in-a-cohort-of-109-patients-over--peer-reviewed-fulltext-article-PTT
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/real-world-experience-of-bimekizumab-in-a-cohort-of-109-patients-over--peer-reviewed-fulltext-article-PTT

Similar Items